Hamid Qaiser Sial, MD
Psychiatry · Visalia
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Sial’s office at (669) 327-8700 to ask if they take your plan before you enroll.
California Medical Board record
Licence A80758 · Current
Licensed to practise in California · since 2002 · expires 2027-12-31 · University of Karachi, Sind Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$0 in 2022
Medicaid paid $0 for 13 billed services this clinician did in 2022, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 13 | $0 |
| 2022 | 13 | 1 | 12 | $0 |
Drugs they prescribed that Part D paid
$39,128
Pharmacies billed $39,128 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 99) in 2024. At or below the middle of the specialty; the typical psychiatry clinician is at 0%.
85 generic and 14 brand-name prescriptions · $39,128 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Gabapentin | 20 | $98 | $5 |
| Fluoxetine | 11 | $37 | $3 |
Year by year
| 2024 | 99 | 12 | 0% (0) | 14% | $39,128 |
| 2023 | 53 | 21 | 0% (0) | None | $8,473 |
| 2022 | 500 | 55 | 0% (0) | 3% | $62,467 |
| 2021 | 448 | 37 | 0% (0) | 4% | $21,215 |
| 2020 | 167 | 16 | 0% (0) | 7% | $4,106 |
| 2013 | 31 | None | 0% (0) | None | $3,235 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2022: 19 drugs
| Aripiprazole | 25 | $6,660 | $266 |
| Quetiapine | 30 | $4,213 | $140 |
| Venlafaxine Hcl Er | 21 | $2,141 | $102 |
| Clozapine | 16 | $1,953 | $122 |
| Olanzapine | 15 | $1,214 | $81 |
| Buspirone | 29 | $879 | $30 |
| Haloperidol | 20 | $749 | $37 |
| Duloxetine | 21 | $617 | $29 |
| Mirtazapine | 18 | $413 | $23 |
| Trazodone | 14 | $392 | $28 |
| Gabapentin | 28 | $377 | $13 |
| Fluoxetine | 21 | $370 | $18 |
| Risperidone | 13 | $318 | $24 |
| Hydroxyzine | 17 | $277 | $16 |
| Clonazepam | 26 | $276 | $11 |
| Bupropion | 12 | $250 | $21 |
| Benztropine Mesylate | 22 | $239 | $11 |
| Lamotrigine | 19 | $185 | $10 |
| Lithium Carbonate | 11 | $74 | $7 |
2021: 16 drugs
| Aripiprazole | 24 | $3,040 | $127 |
| Quetiapine | 61 | $1,473 | $24 |
| Olanzapine | 18 | $692 | $38 |
| Bupropion Xl | 18 | $667 | $37 |
| Divalproex Sodium Er | 13 | $571 | $44 |
| Gabapentin | 30 | $368 | $12 |
| Venlafaxine Hcl Er | 30 | $296 | $10 |
| Buspirone | 29 | $202 | $7 |
| Trazodone | 17 | $164 | $10 |
| Benztropine Mesylate | 13 | $156 | $12 |
| Risperidone | 17 | $147 | $9 |
| Fluoxetine | 20 | $140 | $7 |
| Lithium Carbonate | 12 | $115 | $10 |
| Citalopram Hbr | 14 | $64 | $5 |
| Diazepam | 11 | $38 | $3 |
| Clonazepam | 15 | $25 | $2 |
2020: 1 drug
| Duloxetine | 14 | $143 | $10 |
Money from drug and device companies
$288 in 2024
| 2024 | 5 | 14 | None | $288 |
| 2023 | 4 | 5 | None | $116 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Alkermes | Aristada | $99 | 5 payments
|
| Otsuka America Pharmaceutical | Rexulti | $62 | 3 payments
|
| Indivior | Perseris | $58 | 3 payments
|
| Janssen Pharmaceuticals | Invega Sustenna | $52 | 2 payments
|
| Neurocrine Biosciences | Ingrezza | $16 | 1 payment
|
See all 14 published payments
| Alkermes | Meals · 2024-06-05 | Aristada | $23 |
| Janssen Pharmaceuticals | Meals · 2024-05-08 | Invega Sustenna | $24 |
| Alkermes | Meals · 2024-05-01 | Aristada | $20 |
| Janssen Pharmaceuticals | Meals · 2024-04-10 | Invega Sustenna | $29 |
| Otsuka America Pharmaceutical | Meals · 2024-04-09 | Abilify Maintena | $16 |
| Alkermes | Meals · 2024-03-20 | Aristada | $14 |
| Indivior | Meals · 2024-03-14 | Perseris | $20 |
| Otsuka America Pharmaceutical | Meals · 2024-03-06 | Rexulti | $25 |
| Alkermes | Meals · 2024-02-21 | Lybalvi | $20 |
| Indivior | Meals · 2024-02-14 | Perseris | $20 |
| Otsuka America Pharmaceutical | Meals · 2024-02-07 | Rexulti | $21 |
| Neurocrine Biosciences | Meals · 2024-01-31 | Ingrezza | $16 |
| Indivior | Meals · 2024-01-10 | Perseris | $19 |
| Alkermes | Meals · 2024-01-04 | Aristada | $22 |
See earlier years (2023)
2023: $116
| Teva Pharmaceuticals USA | Uzedy | $37 | 1 payment
|
| Otsuka America Pharmaceutical | Abilify Asimtufii | $36 | 2 payments
|
| Janssen Pharmaceuticals | Invega Sustenna | $23 | 1 payment
|
| Alkermes | Aristada | $20 | 1 payment
|
Professional record
- NPI
- 1003911637
- Licence
- CA A80758California A80758: Current · expires 2027-12-31
More record details
- Sole proprietor
- No
- Medicaid ID
- KS 2087119101, WA 8282170
- Taxonomy
- Psychiatry (2084P0800X); Federal specialty code 2084A0401X (2084A0401X); Federal specialty code 2084P0802X (2084P0802X); Federal specialty code 2084P0805X (2084P0805X)
- Mailing address
- 520 E Tulare Ave, Visalia, CA, 93292
- NPI first listed
- 2006-09-14
- NPI last updated
- 2023-09-13
- NPI record certified
- 2023-09-13
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2751 Napa Valley Corporate Dr Ste 217, Napa, CA, 94558 · 751 S Bascom Ave, San Jose, CA, 95128